Set the scientific and operational strategy for Preclinical Sciences, encompassing nonclinical safety, DMPK, and bioanalytical sciences.
Serve as a senior leader within the Research organization, collaborating closely with Discovery, Clinical Development, Regulatory, and Quality to drive candidate advancement and risk mitigation.
Provide thought leadership and decision-making support on IND readiness, dose/exposure rationale, and safety margins.
Represent Preclinical Sciences in governance forums and cross-functional portfolio planning.
Provide strategic leadership in selecting and managing third party vendors that meet industry standards.
Oversee GLP and non-GLP toxicology studies in partnership with internal scientists and external CROs.
Direct in vitro and in vivo DMPK studies, including pharmacokinetic studies to enable and inform clinical modeling and translational assessments.
Lead integration of bioanalysis, toxicokinetics, and potentially biomarker strategy into nonclinical programs to inform clinical development and regulatory submissions.
Drive the development of translational hypotheses and mechanistic understanding of safety, and PK/PD in relevant models.
Provide key scientific input to cross-functional program teams on preclinical results, their implications for clinical/regulatory strategy, and risk mitigation plans.
Lead and inspire a high-performing internal team spanning toxicology, DMPK, and bioanalytical development; foster a culture of scientific rigor, collaboration, and accountability.
Own the strategy and preparation of preclinical sections of regulatory submissions (IND, CTA, IB, BLA, briefing packages, etc.), in collaboration with regulatory and clinical colleagues.
Represent preclinical development in portfolio planning, due diligence, and external collaborations/partnerships.
Participate in regulatory agency interactions as the scientific lead for nonclinical safety, DMPK, and PK/PD.
Cultivate productive partnerships with CROs, and external consultants, to expand capabilities and ensure quality.
Requirements
PhD, DVM, or PharmD in pharmacology, toxicology, pharmaceutical sciences, or related discipline.
15+ years of relevant experience in biotech/pharma R&D, including leadership of toxicology and preclinical development.
Demonstrated track record of leading successful regulatory filings (IND, BLA, etc.) and supporting early- and late-stage clinical development programs.
Expertise in biologics (e.g., monoclonal antibodies, fusion proteins) strongly preferred.
Deep understanding of GLP regulatory requirements, translational science, and nonclinical study design.
Experience overseeing CROs, external consultants, and cross-functional program teams.
Strong leadership, team building, and communication skills; ability to influence functions and levels.
Background in developing and implementing biomarker strategies to inform drug development across preclinical and clinical stages is desirable.
Passion for rare disease research and mission-driven science.